Autophagy Cytokines Mesenteric fat abstract Background: Recently, mesenteric fat has been proposed to play a role in the pathophysiology of Crohn's disease (CD), as fat hypertrophy is detected close to the affected intestinal area; however, there are few studies regarding autophagy and creeping fat tissue in CD.
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Autofagia Citocinas Gordura mesenterial resumo Autofagia e expressão de citocinas pró-inlamatórias na mucosa intestinal e no tecido mesenterial de pacientes com doença de Crohn Introduction Autophagy seems to be essential for intestinal mucosal immunity, and recent studies show that mutations in autophagy-related genes are associated with CD. [1] [2] [3] [4] The autophagy process has important functions, such as regulation of cell survival and cell death. When properly activated, the process promotes survival through the degradation of cytoplasmic organelles and content via lysosomes, thereby providing metabolic fuel for mitochondrial oxidation, 5, 6 as well as accounting for the removal of proteins generated from cellular stress. However, exacerbated autophagy may also lead to cell death. 7, 8 Autophagy can be induced by extracellular and intracellular signals, including oxidative stress, growth factors, ceramide, endoplasmic-reticulum (ER) stress, and glucose and amino acid serum starvation. 9 Association of CD with the gene loci ATG16L1 was refereed and patients who had more mutant alleles, develop more severe course of disease (stenosis and istulae), compared to those patients with inlammatory CD phenotype only. 10 Although there is phenotypic variation in surgical specimens from CD patients, macroscopic aspects are notorious; particularly regarding mesenteric fat thickening near the affected intestinal area. 11 Mesenteric fat hypertrophy and bowel wrapping are characteristic of CD. 12 Histological analyses revealed abnormalities in adipose tissue, including iniltration of macrophages and T cells, perivascular ibrosis and inlammation. Moreover, there are increased numbers of adipocytes in CD creeping fat, which have been reported to be smaller in CD than in controls. 13, 14 Similar to macrophages and epithelial cells, adipocytes from normal individuals are able to synthesize several proinlammatory and anti-inlammatory cytokines, and fat hormones. 15 Indeed, adipocytes can express TLR4 for the recognition of local or systemic bacterial antigens. [16] [17] [18] There have been few reports discussing the role of the mesenteric fat tissue in CD. [19] [20] [21] [22] [23] [24] However, there are no studies evaluating autophagy in this tissue. Therefore, in order to compare the autophagic activity (called 'macroautophagy') and the expression of proinlammatory cytokines in fat and intestinal tissue between CD patients and controls, we used immunoblotting to determine LC3, TNF-α, and IL-23 protein expression. In addition, we performed RT-PCR assays to determine the relative RNA quantiication related to the step of membrane elongation and autophagosome formation (LC3II and Atg16L1) in mesenteric fat tissue groups. 25, 26 
Patients and methods
Mucosal biopsies were taken from 10 patients with ileocecal CD [mean age 34.9 (range, 14-60) years; male 50%; female 50%]. The presence of disease activity was assessed by colonoscopy before surgery, and all patients had Crohn's disease activity index (CDAI) 27 over 250 points. The control groups were composed of eight patients who underwent retosigmoidectomy for non-inlammatory disease (megacolon), with normal distal ileum (ileum mesenteric fat tissue control group) [mean age 55.6 (range, 39-70) years; male 62.5%; female 37.5%], and eight patients with normal ileocolonoscopy (intestinal tissue control group) [mean age 50.4 (range, 33-60) years; male 37.5%; female 62.5%].
The study was approved by the local Ethical Committee. All biopsies were performed after obtaining informed consent from the patients. The study was carried out at the Coloproctology Unit and at the Cell Signaling Laboratory of the Universidade Estadual de Campinas (UNICAMP).
Mucosal biopsies from the terminal ileum and mesenteric fat tissue near the affected intestinal area were snap-frozen in liquid nitrogen and stored at −80 °C until ready to be used.
Western blotting analysis
For total protein extract preparation, the fragments were homogenized in solubilization buffer at 4 ºC [1% Triton X-100, 100 mM Tris-HCl (pH 7.4), 100 mM sodium pyrophosphate, 100 mM sodium luoride, 10 mM EDTA, 10 mM sodium orthovanadate, 2.0 mM phenylmethylsulfonyl luoride (PMSF), and 0.1 mg aprotinin/mL] with a Polytron PTA 20S generator (model PT 10/35; Brinkmann Instruments, Westbury, NY) operated at maximum speed for 30 sec. Insoluble material was removed by centrifugation (20 min at 110,000 rpm at 4 °C). Protein concentration in the supernatants were determined by the Bradford dye binding method. 28 Aliquots of the resulting supernatants containing 50 μg total proteins were separated by SDS-PAGE, transferred to nitrocellulose membranes and blotted with anti-LC3, anti-TNF-α and anti-IL-23 antibodies. 29 Reagents for SDS-PAGE and immunoblotting were from Bio-Rad Laboratories (Richmond, CA). Phenylmethylsulfonyl luoride, aprotinin, Triton X-100, Tween 20, and glycerol were from Sigma (St. Louis, MO). Nitrocellulose paper (BA85, 0.2 μm) was from Amersham (Aylesbury, UK). The anti-LC3 (M115-3, mouse monoclonal) antibody was purchased from MBL International (MA). The anti-TNF-α (sc-1347, rabbit polyclonal) and anti-IL-23 (sc-50303, rabbit polyclonal) antibodies were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Protein molecular weight was assessed by the PageRulerTM from Fermentas (Glenburnie, MD). The signal was detected by chemiluminescent reaction (SuperSignal ® West Pico Chemiluminescent Substrate from Pierce Biothecnology, Inc. Rockford, IL).
All numerical results are expressed as mean ± SEM of the indicated number of experiments. Blotting results are presented as direct comparisons of bands in autoradiographs and quantiied by densitometry using the Gel-Pro Analyzer 6.0 software (Exon-Intron Inc., Farrell, MD). Data were analyzed by the t-Test, comparing the mesenteric fat tissue of the CD group and its respective fat control group; and comparing, separately, the intestinal tissue of the CD group and its respective intestinal control group. The level of signiicance was set at p < 0.05.
RT-PCR analysis
Total RNA was extracted using Trizol (Invitrogen) according to the manufacturer instructions. RNA purity and concentration were determined by UV spectrophotometry at 260 nm. RNA was treated with RNase-free Dnase (RQ1 RNase-free Dnase, Promega), then reverse transcribed using oligo (dT) primers and reverse transcriptase (RevertAid™ Kit, Fermentas). The reaction mixture (20 μl) was incubated at 42 ºC for 60 min, then 10 min at 70 º C, and cooled on ice. RT-PCR was performed on resulting cDNA, using the manufacturer protocol, in 25 μL reaction volume per capillary. Gene-speciic primers (Applied Biosystems™) were: Hs00261291 (MAP1LC3-LC3); Hs00250530 (ATG16-L1); NM_002046.3 (GAPDH). The reaction mixture contained SYBR ® Premix Ex Taq™ II (2x), cDNA template, primer pair mixture and dH 2 O. RT-PCR ampliication consisted of an initial denaturation step (50 ºC for 2 min and 95 ºC for 10 min), 40 cycles of denaturation (95 ºC for 15 seconds), anneling (53 ºC for 20 seconds) and extension (72 ºC for 20 seconds), followed by a inal incubation at 60 ºC for 1 min. All measurements were normalized by the expression of GAPDH gene, considered as a stable housekeeping gene. Gene expression was determined using the delta-delta Ct method:
Real-time PCR analysis of gene expression was performed in a 7500 SDS sequence detection system (Applied Biosystems). The optimal concentration of cDNA and primers, as well as the maximum eficiency of ampliication, were obtained through ive-point, two-fold dilution curve analysis for each gene. Realtime data were analyzed using the Sequence Detector System 1.7 (Applied Biosystems). The t-test was used for statistical analyses, comparing the mesenteric fat tissue of the CD group and its respective fat control group; and comparing, separately, the intestinal tissue of CD group and its respective intestinal control group. The level of signiicance was set at p < 0.05.
Results
LC3-II protein expression was signiicantly lower in the mesenteric fat tissue of CD patients (FCD group), when compared to controls (FC group) (p < 0.05). Patients with CD also had signiicantly higher levels of LC3-II, TNF-α and IL-23 in intestinal mucosa (ICD group) when compared to intestinal control (IC group) (p < 0.05). No difference in cytokine levels was observed among the mesenteric groups. Results are showed in Figs. 1 to 6.
Regarding LC3 and ATG16L1 gene expressions, no statistically signiicant differences were detected when the mesenteric fat tissue groups were compared (p > 0.05). Figs. 7 and 8 illustrate these indings.
Discussion
Recent genome-wide association studies (GWAS) have increased the number of CD associated susceptibility genes. Two of these genes (ATG16L1 and IRGM) modulate autophagy, and the variant T300A of ATG16L1 results in a speciic defect in bacteria-induced autophagy. 3, 30, 31 ATG16L1 and NOD2 risk variants, in addition to Paneth cell defect, could modify intestinal epithelial cell antimicrobial responses. 30 However, there is no report of autophagy-related protein levels in distinct tissues affected by CD, such as intestinal and mesenteric fat tissues.
Autophagy is a cellular process by which a double-membrane structure (autophagosome) surrounds the cytoplasm to break captured proteins and cytoplasmic organelles. 32 Although Beclin-1 is a part of one of the core Atg (autophagyrelated genes) complexes and participates in the initial autophagy process, in the formation of the isolated membrane, LC3-II conjugations are essential for membrane elongation and autophagosome formation and are often used as markers of autophagy. Whereas LC3-I is localized in the cytosol, LC3-II is localized on the cytoplasmic surface of autophagosomes and is delipidated by Atg4B to recycle LC3-I for further autophagosome formation. 33, 34 Indeed, Atg16L1 determines the site of LC3 conjugation, essential for autophagosome formation, suppressing inlammasome activity and maintaining Paneth cells. 35, 36 Despite great progress since the identiication of ATG1, 37 many questions regarding the molecular regulation of autophagy remain unresolved. 38 Moreover, autophagy and inlammatory pathways are closely linked. Proinlammatory cytokines secretion, such as IL-1β and IL-18, were enhanced in ATG16L1 or ATG7 deleted macrophages in response to lipopolysaccharide (LPS), displaying increased susceptibility to a murine model of colitis. 39 Autophagy also suppresses endotoxin-induced inlammatory immune responses. 40 Defects of autophagy activity and bacterial receptors (NOD2) have been associated with impaired antigen presentation, engaged intracellular removal of pathogenic bacteria and, consequently, higher expression of proinlammatory cytokines. [41] [42] [43] [44] [45] Autophagy contributes to cellular survival against nutrient starvation and the turn-over of injured organelles, 46, 47 explaining why in the present study was veriied high expression of autophagy protein in the intestinal tissue of CD patients when compared to controls. However, this ability was not veriied in the hypertrophied mesenteric fat tissue of CD patients, other- wise, was found low expression of LC3-II when compared to mesenteric tissue of patients without IBD. This LC3-II expression could lead to an impaired clearance of bacterial species, as well as the accumulation of unprocessed unnecessary proteins, which activate proinlammatory pathways involved in CD pathogenesis. The higher expression of proinlammatory cytokines in intestinal mucosa, such as TNF-α and IL-23, which signalize respective Th1 and Th17 lymphocyte response, could also explain the higher levels of autophagy protein seen in this study. Although LC3-II protein expression was lower in the mesenteric fat tissue and higher in the intestinal tissue of CD patients, no statistical differences were seen among these groups, considering LC3 and ATG16L1 gene expressions. Reports on the role of microRNAs (miRNAs) in autophagy may lead to insights into these complex processes. MicroRNAs represent an important and still relatively unexplored manner of regulating protein synthesis. It does not encode for proteins, but exert catalytic, structural or regulatory activities by annealing to speciic target RNAs, and downregulating their stability and/or translation. 48, 49 It has been reported that miRNA-101 is a potent inhibitor of autophagy. 50 Regarding CD, Brest et al., showed that a family of miRNAs, miR-196, is overexpressed in the inlammatory intestinal epithelia of these individuals and there is subsequent loss of the tight regulation of IRGM expression, which compromises the control of intracellular replication of CD-associated adherent invasive Escherichia coli by autophagy. The association of IRGM with CD arises from a miRNA-based alteration in IRGM regulation that affects the eficacy of autophagy. 51 The results of the protein and gene expression in the present study suggest that miRNA alterations could be involved in the complete gene transcription, resulting in the defective production of the protein. Only one study reporting a miRNA (miR-204) regulating LC3-II protein has been published, which reported an important role for this mechanism in myocardial injury; 52 however, there are no studies of miRNA, autophagy regulation, and CD in the literature.
Recent studies, in mice, provide insights into how defective autophagy in cells, such as macrophages and Paneth cells, may contribute to CD, 39, 53 although none of these studies describe these alterations in adipose tissue. It is possible that the defective autophagy in this tissue could be responsible for maintaining the local production of inlammatory mediators and lead to intestinal involvement, especially on mesenteric longitudinal side, forming ulcers, characteristic of CD, as described by Crohn et al. 54 In late stages of the disease, there is a decrease in adipocytes number, as these are substituted by impaired autophagic cells of the immune system, such as macrophages, 55, 56 possible explaining why the present study showed a defective autophagy in the mesenteric adipose tissue of CD patients.
The importance in knowing the autophagy pathway in creeping fat tissue in CD can lead us to understand more about the phenotype and molecular biology involved in CD and its pathogenesis, as well as the active role of adipose tissue in the maintenance of the inlammatory process during the course of disease.
Conclusion
The present study shows a defective expression of proteinrelated autophagy in the mesenteric fat tissue of CD patients, when compared to controls. Data suggest that the primary defects of cell autophagy may not occur at all tissue involved by CD, however, it may occur mainly in the adipose tissue, close to the affected intestinal area. The mesenteric fat tissue could play an important role in the maintenance of local inlammation in these patients. Further studies will determine whether miRNA has a role in autophagy regulation in patients with CD, and whether autophagy can be used for therapeutic approaches in the treatment of CD.
